Showing results (1-10 of 74) with videos related to
Sort By:
Pageof 8
Methods in Molecular Biology (Clifton, N.J.)|November 9, 2011
Chemical proteomics in drug discoveryGerard DrewesBioorganic & Medicinal Chemistry|December 2, 2011
Chemoproteomic approaches to drug target identification and drug profilingMarcus Bantscheff, Gerard DrewesCurrent Opinion in Cell Biology|March 22, 2003
Global approaches to protein-protein interactionsGerard Drewes, Tewis BouwmeesterFEBS Letters|November 5, 2003
The protein kinase kin1, the fission yeast orthologue of mammalian MARK/PAR-1, localises to new cell ends after mitosis and is important for bipolar growthGerard Drewes, Paul NurseTrends in Biotechnology|July 19, 2018
Chemoproteomics and Chemical Probes for Target DiscoveryGerard Drewes, Stefan KnappNeuro-Degenerative Diseases|June 29, 2007
Pathway proteomics and chemical proteomics team up in drug discoveryCarsten Hopf, Marcus Bantscheff, Gerard DrewesThe Journal of Biological Chemistry|November 5, 2003
MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomesBernhard Trinczek, Miro Brajenovic, Andreas Ebneth, et al.Molecular & Cellular Proteomics : MCP|August 5, 2008
Chemical and pathway proteomics: powerful tools for oncology drug discovery and personalized health careUlrich Kruse, Marcus Bantscheff, Gerard Drewes, et al.Methods (San Diego, Calif.)|June 13, 2012
Mass spectrometry approaches to monitor protein-drug interactionsNico Zinn, Carsten Hopf, Gerard Drewes, et al.Pageof 8